| Name | Walgreens #11635 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 6708 Ne 63rd St, Vancouver, Washington 98661 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (360) 696-0759 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-erosive GERD.
January is Thyroid Awareness Month, and physicians from the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease and the Department of Otolaryngology – Head and Neck Surgery at the Mount Sinai Health System are emphasizing the importance of being aware of symptoms that may be related to thyroid disease.
Children wearing multifocal contact lenses had slower progression of their myopia, according to results from a clinical trial funded by the National Eye Institute, part of the National Institutes of Health.
Scientists in Switzerland are reporting results of one of the first studies on the release of silver nanoparticles from laundering those anti-odor, anti-bacterial socks now on the market. Their findings, scheduled for the Nov. 1 issue of ACS' journal Environmental Science & Technology, may suggest ways that manufacturers and consumers can minimize the release of these particles to the environment, where they could harm fish and other wildlife.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFIL (posaconazole) injection (18 mg/ mL), a new formulation of NOXAFIL for intravenous (IV) use.
› Verified 5 days ago
| NPI Number | 1649285636 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #11635 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 6708 Ne 63rd St, Vancouver, WA 98661 |
| Phone Number | 360-696-0759 |
News Archive
Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-erosive GERD.
January is Thyroid Awareness Month, and physicians from the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease and the Department of Otolaryngology – Head and Neck Surgery at the Mount Sinai Health System are emphasizing the importance of being aware of symptoms that may be related to thyroid disease.
Children wearing multifocal contact lenses had slower progression of their myopia, according to results from a clinical trial funded by the National Eye Institute, part of the National Institutes of Health.
Scientists in Switzerland are reporting results of one of the first studies on the release of silver nanoparticles from laundering those anti-odor, anti-bacterial socks now on the market. Their findings, scheduled for the Nov. 1 issue of ACS' journal Environmental Science & Technology, may suggest ways that manufacturers and consumers can minimize the release of these particles to the environment, where they could harm fish and other wildlife.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFIL (posaconazole) injection (18 mg/ mL), a new formulation of NOXAFIL for intravenous (IV) use.
› Verified 5 days ago
News Archive
Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-erosive GERD.
January is Thyroid Awareness Month, and physicians from the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease and the Department of Otolaryngology – Head and Neck Surgery at the Mount Sinai Health System are emphasizing the importance of being aware of symptoms that may be related to thyroid disease.
Children wearing multifocal contact lenses had slower progression of their myopia, according to results from a clinical trial funded by the National Eye Institute, part of the National Institutes of Health.
Scientists in Switzerland are reporting results of one of the first studies on the release of silver nanoparticles from laundering those anti-odor, anti-bacterial socks now on the market. Their findings, scheduled for the Nov. 1 issue of ACS' journal Environmental Science & Technology, may suggest ways that manufacturers and consumers can minimize the release of these particles to the environment, where they could harm fish and other wildlife.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFIL (posaconazole) injection (18 mg/ mL), a new formulation of NOXAFIL for intravenous (IV) use.
› Verified 5 days ago
Sav-on Pharmacy #0580 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 14300 Ne 20th Ave, Vancouver, Washington 98686 Phone: (360) 576-4844 | |
Convalescent Equipment And Supply C Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1251 Officers Row, Vancouver, Washington 98661 Phone: (877) 552-3726 | |
Coyote Stone, Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 10818 Ne Coxley Dr, Vancouver, Washington 98662 Phone: (360) 949-7199 | |
Evergreen Prosthetics & Orthotics L Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11201 Ne 9th St, Vancouver, Washington 98684 Phone: (360) 213-2088 | |
Fred Meyer #140 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7700 Ne Highway 99, Vancouver, Washington 98665 Phone: (360) 600-8133 |